Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Stein

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Neurology|January 4, 2023
Clinical and Neurophysiologic Phenotypes in Neonates With <i>BRAT1</i> EncephalopathyEvelina Carapancea, Marie-Coralie Cornet, Mathieu Milh, et al.
Frontiers in Immunology|June 21, 2021
Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset SepsisMirjam Freudenhammer, Konstantinos Karampatsas, Kirsty Le Doare, et al.
The Lancet. Respiratory Medicine|April 21, 2024
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trialSascha Meyer, Johannes Bay, Axel R Franz, et al.
Eclinicalmedicine|December 8, 2025
Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trialMartin Poryo, Ludwig Gortner, Johannes Bay, et al.
JAMA Pediatrics|August 5, 2024
Bifidobacterium and Lactobacillus Probiotics and Gut Dysbiosis in Preterm Infants: The PRIMAL Randomized Clinical TrialThea Van Rossum, Annette Haiß, Rebecca L Knoll, et al.
Eclinicalmedicine|November 10, 2025
Corrigendum to "Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trial"Martin Poryo, Ludwig Gortner, Johannes Bay, et al.
Orphanet Journal of Rare Diseases|September 25, 2012
Reduced elastogenesis: a clue to the arteriosclerosis and emphysematous changes in Schimke immuno-osseous dysplasia?Marie Morimoto, Zhongxin Yu, Peter Stenzel, et al.
Brain : a Journal of Neurology|February 27, 2016
EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagySusan Byrne, Lara Jansen, Jean-Marie U-King-Im, et al.
Human Mutation|November 8, 2006
Schimke immunoosseous dysplasia: suggestions of genetic diversityJ Marietta Clewing, Helen Fryssira, David Goodman, et al.
Journal of Neonatal-Perinatal Medicine|August 21, 2023
Proceedings of the 14th International Newborn Brain Conference: Other forms of brain monitoring, such as NIRS, fMRI, biochemical, etcSanoj Ali, Talal Altamimi, Kim Annink, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Neurology|January 4, 2023
Clinical and Neurophysiologic Phenotypes in Neonates With <i>BRAT1</i> EncephalopathyEvelina Carapancea, Marie-Coralie Cornet, Mathieu Milh, et al.
Frontiers in Immunology|June 21, 2021
Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset SepsisMirjam Freudenhammer, Konstantinos Karampatsas, Kirsty Le Doare, et al.
The Lancet. Respiratory Medicine|April 21, 2024
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trialSascha Meyer, Johannes Bay, Axel R Franz, et al.
Eclinicalmedicine|December 8, 2025
Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trialMartin Poryo, Ludwig Gortner, Johannes Bay, et al.
JAMA Pediatrics|August 5, 2024
Bifidobacterium and Lactobacillus Probiotics and Gut Dysbiosis in Preterm Infants: The PRIMAL Randomized Clinical TrialThea Van Rossum, Annette Haiß, Rebecca L Knoll, et al.
Eclinicalmedicine|November 10, 2025
Corrigendum to "Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trial"Martin Poryo, Ludwig Gortner, Johannes Bay, et al.
Orphanet Journal of Rare Diseases|September 25, 2012
Reduced elastogenesis: a clue to the arteriosclerosis and emphysematous changes in Schimke immuno-osseous dysplasia?Marie Morimoto, Zhongxin Yu, Peter Stenzel, et al.
Brain : a Journal of Neurology|February 27, 2016
EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagySusan Byrne, Lara Jansen, Jean-Marie U-King-Im, et al.
Human Mutation|November 8, 2006
Schimke immunoosseous dysplasia: suggestions of genetic diversityJ Marietta Clewing, Helen Fryssira, David Goodman, et al.
Journal of Neonatal-Perinatal Medicine|August 21, 2023
Proceedings of the 14th International Newborn Brain Conference: Other forms of brain monitoring, such as NIRS, fMRI, biochemical, etcSanoj Ali, Talal Altamimi, Kim Annink, et al.
Pageof 5